Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002913
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
1999-11-01
Brief Title:
Paclitaxel Cisplatin and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Brenner Tumor |
| Ovarian Clear Cell Cystadenocarcinoma |
| Ovarian Endometrioid Adenocarcinoma |
| Ovarian Mixed Epithelial Carcinoma |
| Ovarian Mucinous Cystadenocarcinoma |
| Ovarian Serous Cystadenocarcinoma |
| Ovarian Undifferentiated Adenocarcinoma |
| Stage III Ovarian Epithelial Cancer |
| Stage IV Ovarian Epithelial Cancer |
Keywords: